Clinical Trial: A Study of an Investigational Drug and an Approved Drug in the Treatment of Osteoarthritis

This study is no longer recruiting patients.

Sponsored by: Merck
Information provided by: Merck

Purpose

The purpose of this study is to compare the safety and effectiveness of an investigational drug and an approved drug in the treatment of osteoarthritis of the knee and hip.

Condition Treatment or Intervention Phase
Osteoarthritis
 
Phase II
Phase III

MedlinePlus related topics:  Osteoarthritis

Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study

Eligibility

Ages Eligible for Study:  40 Years and above,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria:

  • Osteoathritis of the knee or hip which requires treatment with a medication to obtain pain relief

Exclusion Criteria:

  • Any known allergy to the study drugs

More Information

Study ID Numbers:  2004_057
Record last reviewed:  September 2004
Last Updated:  October 13, 2004
Record first received:  September 23, 2004
ClinicalTrials.gov Identifier:  NCT00092768
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08


Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Resources